United States Court of Federal Claims, 2021

Andras v. Secretary of Health and Human Services

United States Court of Federal Claims · Decided October 26, 2021 · Thomas L. Gowen

Opinion

In the United States Court of Federal Claims

OFFICE OF SPECIAL MASTERS

Filed: October 5, 2021 * * * * * * * * * ** * * THELMA ANDRAS, * UNPUBLISHED

Petitioner, * No. 20-1036V

v. * Special Master Gowen

SECRETARY OF HEALTH * Stipulation for Award; AND HUMAN SERVICES, * Tdap vaccine; GBS.

* *

Respondent. *

* * * * * * * * * * * * * John Robert Howie, Jr., Howie Law, PC, for petitioner.

Alexa Roggenkamp, U.S. Department of Justice, Washington, D.C., for respondent.

DECISION FOR STIPULATION 1 On August 18, 2020, Thelma Andras (“petitioner”), filed a petition for compensation under the National Vaccine Injury Program. 2 Petition at Preamble (ECF No. 1). Petitioner received a Tdap vaccine on August 10, 2017. Id. at Preamble; Stipulation for Award (ECF No. 33). Petitioner alleges that as a result of receiving the Tdap vaccine, she suffered Guillain-Barre Syndrome (“GBS”). Stipulation at ¶ 4.

On October 5, 2021, respondent filed a stipulation providing that a decision should be entered awarding compensation to petitioner. Respondent denies that the flu vaccine is the cause of petitioner’s alleged injuries, or any other injury or her current condition. Id. at ¶ 6. Nevertheless, maintaining their respective positions, the parties now agree that the issues between them shall be settled and that a decision should be entered awarding the compensation to the petitioner according to the terms of the stipulation attached hereto as Appendix A. Id. at ¶ 7.

The stipulation provides:

1) A lump sum of $47,500.00 in the form of a check payable to petitioner; and 2) A lump sum of $10,000.00, representing reimbursement of a Medicaid lien for services rendered to petitioner by the State of Louisiana, the form of a check payable jointly to petitioner and the Louisiana Department of health, and mailed to:

Louisiana Department of Health c/o Ryan Hart/BIN #20

Bienville Building 628 North 4th Street

P.O. Box 3836 Baton Rouge, Louisiana 70821-3836

Petitioner agrees to endorse this check to the Louisiana Department of Health. These amounts represent compensation for all damages that would be available under 42 U.S.C. § 300aa-15(a).

I adopt the parties’ stipulation attached hereto, and award compensation in the amount and on the terms set forth therein. The Clerk of the Court SHALL ENTER JUDGMENT in accordance with the terms of the parties’ stipulation. 3

IT IS SO ORDERED. s/Thomas L. Gowen Thomas L. Gowen Special Master

1 Pursuant to the E-Government Act of 2002, see 44 U.S.C. § 3501 note (2012), because this opinion contains a reasoned explanation for the action in this case, I am required to post it on the website of the United States Court of Federal Claims. The court’s website is at http://www.uscfc.uscourts.gov/aggregator/sources/7. This means the opinion will be available to anyone with access to the Internet. Before the opinion is posted on the court’s website, each party has 14 days to file a motion requesting redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). “An objecting party must provide the court with a proposed redacted version of the decision.” Id. If neither party files a motion for redaction within 14 days, the opinion will be posted on the court’s website without any changes. Id. 2 The National Vaccine Injury Compensation Program is set forth in Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended, 42 U.S.C. §§ 300aa-1 to -34 (2012) (Vaccine Act or the Act). All citations in this decision to individual sections of the Vaccine Act are to 42 U.S.C.A. § 300aa. 3 Entry of judgment is expedited by each party’s filing notice renouncing the right to seek review. Vaccine Rule 11(a).

Case-law data current through September 30, 2026. Source: CourtListener bulk data.